Page last updated: 2024-12-11

sibiromycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6437361
CHEMBL ID462584
CHEBI ID90941
MeSH IDM0263386

Synonyms (14)

Synonym
sybiromycin
sibiromycin ,
5h-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one, 7-((4,6-dideoxy-3-c-methyl-4-(methylamino)-alpha-l-mannopyranosyl)oxy)-1,10,11,11a-treahydro-9,11-dihydroxy-8-methyl-2-(1e)-1-propenyl-, (11r,11as)-
CHEMBL462584
(6r,6as)-2-[(2s,3r,4r,5s,6s)-3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy-4,6-dihydroxy-3-methyl-8-[(e)-prop-1-enyl]-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one
12684-33-2
(11r,11as)-9,11-dihydroxy-8-methyl-5-oxo-2-[(1e)-prop-1-en-1-yl]-5,10,11,11a-tetrahydro-1h-pyrrolo[2,1-][1,4]benzodiazepin-7-yl 4,6-dideoxy-3-c-methyl-4-(methylamino)-alpha-l-mannopyranoside
CHEBI:90941
Q27162933
EX-A5057
DTXSID101318295
CS-0179607
HY-N9460
AKOS040756608

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" 4 days post dosing ethylmorphine demethylase and aniline hydroxylase activities in liver 9000 g supernatant were depressed from 26 to 76%."( Acute treatment with pyrrolo(1,4)benzodiazepine antitumor antibiotics alters in vitro hepatic drug metabolizing activity in rats.
Atkinson, JE; Lubawy, WC, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
pyrrolobenzodiazepineAny organic heterotricyclic compound with a skeleton consisting of a pyrrole ring ortho-fused at any position to a benzodiazepine bicyclic system.
aminoglycoside antibiotic
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
hemiaminalAny organic amino compound that has an amino group and a hydroxy group attached to the same carbon atom. Hemiaminals are intermediates in the formation of imines by addition of an amine to an aldehyde or ketone; those derived from primary amines are particularly unstable.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID487198Binding affinity to calf thymus DNA assessed as change in melting temperature after 4 hrs2010Journal of medicinal chemistry, Apr-08, Volume: 53, Issue:7
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents.
AID487201Binding affinity to calf thymus DNA assessed as change in melting temperature after 18 hrs2010Journal of medicinal chemistry, Apr-08, Volume: 53, Issue:7
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents.
AID487197Growth inhibition of human NCI60 cells after 48 hrs by SRB assay2010Journal of medicinal chemistry, Apr-08, Volume: 53, Issue:7
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents.
AID487202Cytotoxicity against human K562 cells after 96 hrs by alamar blue assay2010Journal of medicinal chemistry, Apr-08, Volume: 53, Issue:7
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (43.48)18.7374
1990's2 (8.70)18.2507
2000's3 (13.04)29.6817
2010's8 (34.78)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.12 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]